In the last trading session, 1.13 million shares of the NLS Pharmaceutics Ltd (NASDAQ:NLSP) were traded, and its beta was -0.49. Most recently the company’s share price was $1.98, and it changed around -$0.02 or -1.00% from the last close, which brings the market valuation of the company to $4.89M. NLSP currently trades at a discount to its 52-week high of $24.34, offering almost -1129.29% off that amount. The share price’s 52-week low was $1.95, which indicates that the current value has risen by an impressive 1.52% since then. We note from NLS Pharmaceutics Ltd’s average daily trading volume that its 10-day average is 0.46 million shares, with the 3-month average coming to 283.23K.
NLS Pharmaceutics Ltd stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended NLSP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. NLS Pharmaceutics Ltd is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Instantly NLSP has showed a red trend with a performance of -1.00% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.23 on recent trading dayincreased the stock’s daily price by 38.7%. The company’s shares are currently down -91.61% year-to-date, but still down -26.39% over the last five days. On the other hand, NLS Pharmaceutics Ltd (NASDAQ:NLSP) is -49.75% down in the 30-day period. We can see from the shorts that 84932.0 shares have been sold at a short interest cover period of 0.15 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 7.15%.
NLSP Dividends
NLS Pharmaceutics Ltd’s next quarterly earnings report is expected to be released in January.
ARMISTICE CAPITAL, LLC, with 6.0535% or 2.31 million shares worth $0.5 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
